HomeAdvisors

https://bhvpartners.com/wp-content/uploads/2019/12/BHVPartners_FranciscoAguado_web.jpg

Head of R&D and Medical Project Management at Boehringer Ingelheim EspañaFrancisco Aguado, MD

Head of R&D and Medical Project Management at Boehringer Ingelheim España. He is a health professional with a medical and clinical background and extensive experience in the pharmaceutical sector managing a portfolio of research, development and innovation projects at all stages of maturity. He has taught at various universities and business schools. His areas of expertise and interest include health and medicine, science and innovation management, drug and device development, project and portfolio management, entrepreneurship, scouting, outsourcing, training and education.

Serial entrepreneurJaume Amat

After twenty years of experience, Jaume Amat has been involved as a founder in more than 10 biomedical start-ups.

He is a Telecommunications Engineers with business formation from IESE (PDD), Motivation and Leadership from Auckland Business School and Social Leadership from ESADE.

https://bhvpartners.com/wp-content/uploads/2020/06/Jaume-Amat-B-n.png
https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_JosepBrugada_web.jpg

Professor of Cardiology at the University of BarcelonaJosep Brugada, MD, PhD

Professor of Medicine at the University of Barcelona, director of the Paediatric Arrhythmia Unit at Hospital Sant Joan de Déu, a senior consultant at Hospital Clinic Barcelona and president of the Brugada Foundation. He was chief of Cardiology and medical director of Hospital Clinic Barcelona from 2006-2014. Also, he was president of the European Heart Rhythm Association (EHRA) and vice president of the Spanish Society of Cardiology. His contribution to the medical community is extensive, including more than 400 publications on cardiac arrhythmias and 300 international lectures.

Director of Diagnostic Imaging Department Hospital Clínic of BarcelonaLluís Donoso-Bach, PhD

Dr. Donoso-Bach has been specially focused in the development and implementation of IT in diagnostic radiology. He served as President of the Spanish Society for Diagnostic Radiology (SERAM), President of the Spanish Foundation of Radiology and President European Society of Radiology (ESR). Recently he was nominated President of the International Society of Strategic Studies in Radiology (IS3R) and President of the International Society of Radiology (ISR). He has received numerous honours for his contributions to the discipline, including the Gold Medal of the SERAM, the Gold Medal of the Interamerican College of Radiology (CIR) and the Gold Medal of the ESR as well as numerous honorary memberships in radiological societies around the globe.

https://bhvpartners.com/wp-content/uploads/2020/09/Luis-Donoso-BN.jpg
https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_GemmaEstrada_web.jpg

Director Digital Health and Technology at FerrerGemma Estrada, PhD

Director of Digital Health and Technology at Ferrer, where she leads the collective effort to reimagine the company by leveraging “digital” on behalf of patients, doctors, payers, partners and employees to have asustainable impact on healthcare. She transitioned to digital health in 2018 after 23 years in clinical development at pharma companies and CROs, as well as in the public sector (Catalan Ministry of Health). She holds a PhD in Biochemistry and Molecular Biology from the University of Barcelona, New England Medical Center (Tufts University, Boston), and an Executive Management Degree from ESADE.

Operations Director at UriachXavier Farrés, PhD

Since 2013, he has been director of Operations at Uriach and is on this pharmaceutical corporation’s board of directors. Previously, he worked at Synthon Hispania, Sanofi-Aventis and Divasa-Farmavic. He is also a mentor for IQS Next Tech, the first industrial acceleration programme in Spain. He holds a PhD in Pharmacy from the University of Barcelona, a PPD from IESE and completed the Leadership Programme at ESADE.

https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_XavierFarres_web.jpg
https://bhvpartners.com/wp-content/uploads/2020/04/ERG-bio-photo-Ellen-Goldberg-B-N.png

President of CHORD ConsultingEllen Goldberg

Ellen Goldberg is Founder and President of CHORD Consulting, which provides product and marketing strategy consulting to innovative companies driving step-change improvements in healthcare. Ellen has focused her career on developing and commercializing ground-breaking products in life-altering diseases. She led marketing at Genomic Health, Inc., where she launched the Oncotype DX® Breast Cancer Assay which empowers >80,000 women annually to make better decisions about chemotherapy.  As VP of Marketing at Crescendo Bioscience, she launched Vectra DA® to help improve outcomes in rheumatoid arthritis. Ellen began her career at Booz Allen & Hamilton and developed new products at ALZA Corp.  Ellen has an MS in Chemistry and an MBA from Stanford University and a BS from Yale University.

Biomedical venture builder and entrepreneurFederico Grego

Biomedical venture builder and entrepreneur with over 20 years of senior management experience in the biopharmaceutical sector, coupled with close to 5 years of investment banking experience. Broad subject matter expertise ranging from innovation management to commercial operations, and general management at an international level. He holds a Bachelor of Economics from Tufts University, MBA from IESE, and an Advanced Management Program from Harvard Business School.

https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_FedericoGrego_web.jpg
https://bhvpartners.com/wp-content/uploads/2020/06/Joaquín-Gómez-Moya-1-B-B.png

CEO at NewmanbrainJoaquín Gómez Moya

MBA, experienced CEO and board director in the biosanitary field, specialized in mergers and acquisitions, as in the incorporation, venture capital funding and launching of spinoffs. He has closed joint development and marketing agreements on four continents and is considered an expert in open innovation. He advises corporates and governmental bodies on novel technologies valuation, and have been coordinating committees of experts, mainly in biotechnology and biomedical technologies, for more than two decades. His last works are related to fields such as CAR-T cells therapies, diagnostics devices, nanosensors national industry development (abroad, on a World Bank-funded mission), global strategic alliances to develop AI-based systems, nanotech for drug delivery; he is currently a member at several director boards, and investments committees.

CEO of Perfect DashboardAleksander Kuczek

Serial entrepreneur, technology executive and advisor to numerous start-ups in the US and Europe. As a 15-year veteran of the tech industry (SaaS, cloud and digital marketing), he has been working with the leading tech providers in this arena. Most recently, he co-founded and served as CEO at Perfect Dashboard. He is an ambassador to Berkeley SkyDeck, the official accelerator of UC Berkeley in California, and teaches the entrepreneurship and start-up course at AGH University of Science and Technology.

https://bhvpartners.com/wp-content/uploads/2019/12/BHVPartners_AleksanderKuczek_web.jpg
https://bhvpartners.com/wp-content/uploads/2020/09/Luciano-lossendiere.jpg

EntrepreneurLuciano Lossendière

Health and business entrepreneur with over 15 years of management experience in the health  sector, coupled with close to 8 years of helicopter and tourism experience. Broad subject matter expertise ranging from innovation management to commercial operations, and general management at an international level. He holds a Bachelor of Business, MBHealth from EADA, and Digital Product Managament. Nuclio Digital School. Barcelona.

Head of urology service at Fundació PuigvertFélix Millán, PhD

Doctor of medicine and surgery. Urology specialist. Subspecialty: lithiasis and endourology. Clinical Head of the Urology Service of the Puigvert Foundation.
Master in Design and Statistics in Health Sciences. Integrative Medicine.

https://bhvpartners.com/wp-content/uploads/2020/06/Felix-Millán.png
https://bhvpartners.com/wp-content/uploads/2020/09/Pascal-Nizet-BN.jpg

Founder and partner at Pharmaphenix and Asderco. Board Member at Accure Therapeutics. Pascal Nizet

Seasonal entrepreneur with a broad international experience in healthcare industry, instrumental in cross cultural business agreements. Over 20 years’ in international marketing, sales, and portfolio management positions. Board member of start-up biotech companies.

Master in Business Administration, CEMS degree, ESADE Business School, Barcelona, Spain; Commercial Engineer & Business Administration, Université Catholique de Louvain, Belgium

Founder and partner at Laboratorios Asderco (Spain), Board Member of Accure Therapeutics (Spain), Founder and partner at Pharmaphenix (Spain), Business Development Europe at Reaction Biology, (USA), Director Strategic Marketing and Business Development, Laboratorios Rubio (Spain), International Marketing Manager / Area Manager, Almirall (Spain).

President of GP PharmAntonio Parente, PhD


PhD in Organic Chemistry. MBA by ESADE and a PADE by IESE. He is linked to more than 10 Biotech companies in Spain performing as a Consultant Assessor and/or Business Angel.

Dr. Parente started his career in Laboratorios Vita S.A. Since 1989, he has been co-founder of several companies, – including Lipotec SA, BCN Peptides SA, Diverdrugs SL, Lipofoods SA, BCN Corp SL and Primaderm SA – where he acted as Manager, CEO or Executive President . In 2000, he founded GP Pharm where he is current President.

Besides these activities, Dr. Parente is at the Business Council of the Centre for Genomic Regulation (CRG Barcelona) and was Vice-president of ASEBIO (Spanish Association of Biotech companies), Co-founder, President and Vice-president of CataloniaBio (Catalan Association of Biotech companies ) and Vice-president of Biocat (Foundation to Promote Life Science Sector in Catalonia).

https://bhvpartners.com/wp-content/uploads/2020/06/Antonio-Parente-B-N.png
https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_DavidReyero_web.jpg

HR Business Partner at Sanofi IberiaDavid Reyero

He has 20 years of experience in human resources (HR) in a wide variety of business sectors and cycles: pharmaceutics (Sanofi), consultancy (Buck Consultants), online banking (Uno-e and BBVA group) and telecommunications (Broadnet). He held national and international executive positions at all of these companies and was in close contact with start-ups and innovation ecosystems. He has a degree in Economics from the University of Leon and an MBA from IE Business School. He collaborates with several business schools, business associations (AEDIPE, Barcelona Global, AED and CírculoEcuestre) and media outlets, and is co-author of the book Control 2.0.

Mentor in the EIT Health Mentoring & Coaching Network and entrepreneurLuis Ruiz-Ávila, PhD

Luis Ruiz-Ávila is mentor in the EIT Health Mentoring & Coaching Network (MCN) and a serial entrepreneur. After ten years of academic research in Spain and the US, in 1997, he started his business career at Almirall. He helped start-up Advancell, Janus Developments (currently Spherium Biomed) and ERA Biotech (currently ZIP Solutions). In recent years, he has held in executive positions at several biotechnology companies, including Aquilón CyL and Biosintaxis. He was a member of the Spanish Association of Biocompanies board (2004-2008) and co-founder of CataloniaBio. He has a PhD in Molecular Genetics from the University of Barcelona and a PADE from IESE.

https://bhvpartners.com/wp-content/uploads/2019/12/BHVPartners_LuisRuiz_web.jpg
https://bhvpartners.com/wp-content/uploads/2019/11/BHVPartners_MarkSefton_web.jpg

Founder and Managing Director of BiomedRedMark Sefton, PhD

Founder and managing director of BiomedRed, a Spanish-based scientific communications and consultancy company. He has experience in preparing, translating and editing biomedical texts for publication, preparing grant proposals, administrative management ofsuccessful EU consortia, and preparing multimedia material for the diffusion and dissemination of scientific activities. He holds a PhD from the University of Cambridge.

Chief Medical Officer of ASC TherapeuticsOscar Segurado, PhD

Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and medical affairs.

Chief Medical Officer of ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie.

Senior medical leader experienced in matrixed, line management and consulting for biotechs, midsize and large pharma companies. Extensive expertise in gene therapy, immuno-oncology , immuno-therapy, genomics and protein/cell diagnostics, predominantly focused on oncology, hematology and autoimmunity, including personalized medicine, molecular and cellular biomarkers.

Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain.

https://bhvpartners.com/wp-content/uploads/2020/06/Oscar-Segurado.png
https://bhvpartners.com/wp-content/uploads/2020/05/Jordi-Serrano-B-N.png

Medical doctor and founder & CEO of UniversalDoctorJordi Serrano Pons, PhD, MD

Dr. Jordi Serrano Pons is a medical doctor and founder & CEO of UniversalDoctor: The Digital Global Health Company. UniversalDoctor won the United Nations World Summit Award for Global Champion of the mHealth category in 2015 and has implemented Digital Global Health projects in more than 20 countries.

Jordi is a widely recognized leader in the digital health and innovation space, consulting for the World Health Organization (WHO) and other key health institutions. He was recently named one of the Top 50 Healthcare IT Leaders in Europe as part of the Future50 classification, supported by IBM Watson Health, a new initiative by HIMSSEurope.

Jordi is also the co-founder of Zero Mothers Die, a global partnership initiative reducing maternal mortality through mobile technology solutions.

https://bhvpartners.com/wp-content/uploads/2019/01/BHV_logo_negatiu_PNG-2.png
https://bhvpartners.com/wp-content/uploads/2019/03/BHV_logo_claim.png

© BHV Partners, 2020. All rights reserved | Sitemap · Legal disclaimer · Privacy policy · Cookies policy

Created by

We use our own and third party cookies to improve your experience and to optimize the operation on the web. If you continue browsing we consider that you accept our cookies policy. More information

La configuració de les galetes d'aquesta web està definida com a "permet galetes" per poder oferir-te una millor experiència de navegació. Si continues utilitzant aquest lloc web sense canviar la configuració de galetes o bé cliques a "Acceptar" entendrem que hi estàs d'acord.

Tanca